Interestingly, some of the non-steroidal anti-inflammatory drugs used in cancer therapy and in the treatment of rheumatoid arthritis and diabetes have been reported to have PPAR-α or PPAR-γ agonist activity [47], [48] (Supplementary Figure S5). Here, PPARA is linked to diabetes mellitus.